We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Results for
"[search-keyword]"
Sponsor content
33 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Recordati Rare Diseases Australia Pty Ltd - Subcutaneous/intramuscular injection set, medicated.
-
Cancellation by sponsorRequested by Recordati Rare Diseases Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISTURISA osilodrostat (as phosphate) 5 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISTURISA osilodrostat (as phosphate) 10 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISTURISA osilodrostat (as phosphate) 1 mg film-coated tablet blister pack.
-
CYSTADROPS - mercaptamine (cysteamine) (as hydrochloride) 3.8 mg/mL eye drops solution vial (351010)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CYSTADROPS - mercaptamine (cysteamine) (as hydrochloride) 3.8 mg/mL eye drops solution vial. -
Australian Public Assessment Report (AusPAR)AusPAR for Isturisa (osilodrostat as phosphate) for the treatment of endogenous Cushing’s syndrome in adults.
-
-
Prescription medicine registrationActive ingredients: osilodrostat phosphate.
-
Prescription medicine registrationActive ingredients: mercaptamine (cysteamine).